Question to the Department for Business, Innovation, Science and Trade:

To ask the Secretary of State for Business, Innovation, Science and Trade, pursuant to the Answer of 21 October 2026 to Question 34312 on Animal Experiments: Dogs, what steps his Department is taking to replace the use of dogs and non-human primates in regulatory toxicology, other than for dedicated pharmacokinetic and cardiovascular safety studies.

The Government is supporting the replacement of dogs and non-human primates in regulatory toxicology through the Replacing Animals in Science strategy, which accelerates the development, validation and uptake of alternative methods. This includes investment in innovative human-relevant technologies, regulatory reforms by the Medicines and Healthcare products Regulatory Agency to support the use of non-animal data, and the establishment of the preclinical translational models hub and UK Centre for the Validation of Alternative Methods. The use of dogs and non-human primates remains subject to stringent controls and is permitted only where no validated alternative exists.